Literature DB >> 11592785

Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture.

V Borrelli1, A V Sterpetti, P Coluccia, B Randone, A Cavallaro, L Santoro D'Angelo, A Cucina.   

Abstract

BACKGROUND: The role of thrombin in the stimulation of endothelial cell (EC) proliferation is controversial. The aim of this study was to investigate if thrombin regulates cell proliferation and production of platelet-derived growth factor (PDGF), bovine fibroblast growth factor (bFGF), and transforming growth factor beta(1) (TGF-beta(1)) by bovine aortic ECs.
METHODS: ECs, obtained from thoracic aortas of calves, were stimulated with thrombin at various concentrations (from 0.05 to 1.0 IU/ml) in serum free culture. Mitogenic activity of thrombin on ECs was determined by tritiated thymidine uptake. The release of PDGF, bFGF, and TGF-beta(1) was assessed by ELISA. PDGF release was confirmed by Western blot and bFGF and TGF-beta(1) mRNA expression was determined by polymerase chain reaction (PCR).
RESULTS: Thrombin at high concentrations did not cause any increase in EC proliferation after 72 h of culture and induced inhibition of EC proliferation after 96 h and 8 days of culture. It induced a decrease in PDGF release and an increase in TGF-beta(1) release. Thrombin at low concentrations induced a significant increase in EC proliferation at 72 h, 96 h, and 8 days of culture. It induced an increase in PDGF release and a decrease in TGF-beta(1) release. bFGF release was higher than control at all thrombin concentrations. These data were confirmed by Western blot and PCR studies.
CONCLUSIONS: Thrombin regulates EC growth through the inhibition of EC proliferation at high concentrations and through the stimulation of EC proliferation at low physiological concentrations. EC proliferation is partially mediated by autocrine production of PDGF, bFGF, and TGF-beta(1). Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592785     DOI: 10.1006/jsre.2001.6231

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.

Authors:  Rohun U Palekar; Chandu Vemuri; Jon N Marsh; Batool Arif; Samuel A Wickline
Journal:  J Vasc Surg       Date:  2015-10-17       Impact factor: 4.268

2.  Transcriptional regulation of platelet-derived growth factor-B chain by thrombin in endothelial cells: involvement of Egr-1 and CREB-binding protein.

Authors:  Jing Chen; Lin Xu; Sisi Chen; Jian Yang; Hong Jiang
Journal:  Mol Cell Biochem       Date:  2012-04-10       Impact factor: 3.396

3.  Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material.

Authors:  Eun-Seok Kim; Jae-Jin Kim; Eun-Jin Park
Journal:  J Adv Prosthodont       Date:  2010-03-31       Impact factor: 1.904

4.  Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.

Authors:  Anke C Fender; Goran Pavic; Grant R Drummond; Gregory J Dusting; Rebecca H Ritchie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-01       Impact factor: 3.000

5.  Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2.

Authors:  Eun-Jin Park; Eun-Seok Kim; Hans-Peter Weber; Robert F Wright; David J Mooney
Journal:  Int J Oral Maxillofac Implants       Date:  2008 Sep-Oct       Impact factor: 2.804

6.  Effects of gamma interferon, interleukin-10, and transforming growth factor beta on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle.

Authors:  M S Khalifeh; J R Stabel
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.